SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-097271
Filing Date
2021-07-29
Accepted
2021-07-29 08:00:36
Documents
15
Period of Report
2021-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2123609d1_8k.htm   iXBRL 8-K 35766
2 EXHIBIT 10.1 tm2123609d1_ex10-1.htm EX-10.1 108934
3 EXHIBIT 99.1 tm2123609d1_ex99-1.htm EX-99.1 11387
7 GRAPHIC tm2123609d1_ex99-1img01.jpg GRAPHIC 2885
  Complete submission text file 0001104659-21-097271.txt   369343

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ruby-20210726.xsd EX-101.SCH 3188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ruby-20210726_lab.xml EX-101.LAB 34593
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ruby-20210726_pre.xml EX-101.PRE 22712
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2123609d1_8k_htm.xml XML 3721
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38586 | Film No.: 211124879
SIC: 2836 Biological Products, (No Diagnostic Substances)